{"product_id":"oregon-health-science-neuroimmunology","title":"Oregon Health \u0026 Science 8th Annual MS and CNS Neuroimmunology Symposium 2025","description":"\u003cdiv class=\"prod-edition\"\u003e\n\u003cdiv class=\"field field--name-field-heading field--type-heading field--label-hidden field__item\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003cdiv class=\"elementor-element elementor-element-bbb44b8 elementor-widget elementor-widget-heading\" data-element_type=\"widget\" data-id=\"bbb44b8\" data-widget_type=\"heading.default\"\u003e\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\n\u003ch3\u003eOregon Health \u0026amp; Science 8th Annual MS and CNS Neuroimmunology Symposium\u003c\/h3\u003e\n\u003cstrong\u003eInclude: 6 videos + 6 audios + 6 file sub vtt + 1 pdf, size: 2 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Target Audience: neurologists, neuroimmunologists, rheumatologists, ophthalmologists, neurosurgeons, physicians\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eOctober 11, 2025\u003c\/strong\u003e\u003cbr\u003e8:30 a.m. – 12:30 p.m.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eVirtual symposium\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"paragraph paragraph--type--text-block paragraph--view-mode--default\" id=\"section-2236106\"\u003e\n\u003cbr\u003e\u003cbr\u003eThis accredited half-day symposium provides health care professionals information to identify, refer, treat and\/or implement practice changes to improve the care of patients with neuroimmunological disorders. Specific disorders discussed this year include a 2 part update on Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy, stopping therapy in MS, Transverse myelitis, Anti-Amyloid Therapies, and managing fatigue.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eWho should attend\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eNeurologists, neuroimmunologists, rheumatologists, ophthalmologists, neurosurgeons, physicians, nurse practitioners, rehabilitation including physical and occupational therapists, researchers, and other medical professionals in the field of neuroimmunological disorders are invited to attend.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"paragraph paragraph--type--text-block paragraph--view-mode--default\" id=\"section-2236111\"\u003e\n\u003ch3\u003eLearning objectives\u003c\/h3\u003e\n\u003cbr\u003eIn Oregon Health \u0026amp; Science 8th Annual MS and CNS Neuroimmunology Symposium 2025 you will learn:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eIdentify current diagnostic criteria and treatment updates for myasthenia gravis\u003c\/li\u003e\n\u003cli\u003eRecognize clinical features and apply updated management strategies for chronic inflammatory demyelinating polyneuropathy (CIDP)\u003c\/li\u003e\n\u003cli\u003eEvaluate appropriate criteria and timing for discontinuing disease-modifying therapies in multiple sclerosis patients\u003c\/li\u003e\n\u003cli\u003eAnalyze case-based presentations of transverse myelitis to improve diagnostic accuracy and treatment decision-making\u003c\/li\u003e\n\u003cli\u003eImplement evidence-based strategies for managing fatigue in patients with multiple sclerosis\u003c\/li\u003e\n\u003cli\u003eAssess patient eligibility and monitoring requirements for anti-amyloid therapies in early-stage Alzheimer’s disease\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e01 Neuromuscular Part I Myasthenia Gravis – Updates\u003c\/li\u003e\n\u003cli\u003e02 Neuromuscular Part II Chronic Inflammatory Demyelinating Polyneuropathy – Updates\u003c\/li\u003e\n\u003cli\u003e03 When to stop therapy, discontinuing DMT in MS\u003c\/li\u003e\n\u003cli\u003e04 Transverse myelitis, a case-based discussion\u003c\/li\u003e\n\u003cli\u003e05 Managing Fatigue in MS\u003c\/li\u003e\n\u003cli\u003e06 Anti-Amyloid Therapies for the Treatment of Early-Stage Alzheimer’s disease\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954538680418,"sku":"MED-AMB05654","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/file_000000000f0871f49ff7813d91646c04.png?v=1779379273","url":"https:\/\/meducourse.com\/products\/oregon-health-science-neuroimmunology","provider":"Meducourse","version":"1.0","type":"link"}